Mather Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.5K Buy
101
+79
+359% +$9.31K ﹤0.01% 1604
2026
Q2
$2.35K Buy
22
+13
+144% +$1.57K ﹤0.01% 1720
2026
Q1
$1.47K Buy
+9
New +$1.38K ﹤0.01% 1733
2025
Q2
– Sell
-70
Closed -$5.34K – 1148
2025
Q1
$5.34K Buy
+70
New +$5.36K ﹤0.01% 1394
2024
Q3
– Sell
-100
Closed -$2.71K – 1941
2024
Q2
$2.71K Hold
100
– – ﹤0.01% 1804
2024
Q1
$3.1K Buy
+100
New +$2.8K ﹤0.01% 1453

Other funds holding INSM

Mather Group's INSM Position: Q3 2026 in Review

Mather Group increased its Insmed (INSM) stake by 359% in Q3 2026, buying an estimated $9.31K and bringing the position to 101 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Mather Group first reported a position in INSM in Q1 2024 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Mather Group held 101 shares of Insmed worth $11.5K as of Q3 2026.
  • Mather Group bought 79 Insmed shares in Q3 2026, an estimated $9.31K.
  • Insmed made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1604 holding.
  • Mather Group first reported a position in Insmed in Q1 2024 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.